About this Video

• Video Title: This Longevity Supplement is a Rip Off!
• Channel: The Anti Aging Channel
• Speakers: The speaker's name is not explicitly mentioned in the transcript.
• Duration: 00:11:41

Introduction

This video investigates TA-65, a costly longevity supplement, exposing its exaggerated health claims and the true nature of its active ingredient. The presenter reveals that the main component can be purchased at a significantly lower price from other sources. The video also details the marketing strategies used and legal actions taken against the company.

Key Takeaways

• TA-65, costing up to $800 per month, is a massively overpriced supplement.
• The main active ingredient in TA-65 is cycloastragenol, a component of astragalus readily available at a fraction of the cost.
• TA-65 was aggressively marketed online, promoted by celebrities and figures like David Wolfe, and made unsubstantiated health claims.
• The Federal Trade Commission (FTC) investigated and sued TA Sciences for deceptive advertising, resulting in a settlement.
• While TA-65 may offer some telomerase activation benefits at low dosages, there's no evidence it's superior to other cycloastragenol extracts or extends lifespan.

Here are the answers based on the provided transcript:

1. Company and License: TA-65 is sold by TS Sciences under a license from the Geron Corporation.

2. Fillers and Flow Agents: The TA-65 capsules contain microcrystalline cellulose, hypromellose, and silica as binders, fillers, and flow agents.

3. Misleading Claims (FTC Lawsuit): TA Sciences made false and deceptive advertising claims for TA-65. The FTC also charged that TA Sciences deceptively represented that consumers in its ads were independent users expressing impartial opinions, when in fact they received free bottles of TA-65 in exchange for their endorsements. The FTC's customer notification letter outlines misleading claims that TA-65 was proven to reverse aging, prevent or reduce cancer risk, increase energy and endurance, and provide other unsubstantiated health benefits.

4. Human Study Findings and Funding: The Barcelona study (2016) found that those taking one capsule of TA-65 daily experienced increased telomere length, while the placebo group experienced a decrease. Those taking four capsules daily showed no statistically significant changes. This study was funded by TA Sciences, and the researchers were either employed by or consulted for TA Sciences.